Mesoblast Ltd ADR (NASDAQ:MESO) shares, rose in value, with the stock price down by -4.10% to the previous day’s close as strong demand from buyers drove the stock to $6.32.
Actively observing the price movement in the last trading, the stock closed the session at $6.59. The value of beta (5-year monthly) was 2.48. Referring to stock’s 52-week performance, its high was $10.24, and the low was $1.61. On the whole, MESO has fluctuated by 208.29% over the past month.
As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.32, which is expected to increase to -$0.4 for fiscal year -$0.72 and then to about -$0.78 by fiscal year 2025. Data indicates that the EPS growth is expected to be 35.10% in 2025, while the next year’s EPS growth is forecast to be -8.30%.
Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $7.3 million, representing a decrease of -2.70% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that MESO’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 25% Buy while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MESO currently trading nearly 111.47% and 170.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 82.02, while the 7-day volatility ratio is showing 22.27% which for the 30-day chart, stands at 13.98%. Furthermore, Mesoblast Ltd ADR (MESO)’s beta value is 3.56, and its average true range (ATR) is 0.62.
A comparison of Mesoblast Ltd ADR (MESO) with its peers suggests the former has fared considerably weaker in the market. MESO showed an intraday change of -4.10% in last session, and over the past year, it grew by 2.60%%.
Data on historical trading for Mesoblast Ltd ADR (NASDAQ:MESO) indicates that the trading volumes over the past 10 days have averaged 12.29 million and over the past 3 months, they’ve averaged 2.14 million. According to company’s latest data on outstanding shares, there are 85.82 million shares outstanding.
Mesoblast Ltd ADR’s shares belong to company insiders and institutional investors own 0.64% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.51 million shares as on Mar 15, 2024, resulting in a short ratio of 0.91. According to the data, the short interest in Mesoblast Ltd ADR (MESO) stood at 0.79% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.54 million. The stock has risen by 187.27% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MESO stock heading into the next quarter.
